Sgalla, Giacomo
Sgalla, Giacomo
ROMA - Dipartimento di Scienze cardiovascolari e pneumologiche
Case of a 33-Year-Old Woman With Hemoptysis and Migrant Nodular Cavitary Lesions
2024 Varone, Francesco; Martini, Alessia; Cicchetti, Giuseppe; Iovene, Bruno; Sgalla, Giacomo; Richeldi, Luca; Cancellieri, Alessandra
Experimental autotaxin inhibitors for the treatment of idiopathic pulmonary fibrosis
2024 Simonetti, Jacopo; Ficili, Marco; Sgalla, Giacomo; Richeldi, Luca
Promising advances in treatments for the management of idiopathic pulmonary fibrosis
2024 Sofia, Carmelo; Comes, Alessia; Sgalla, Giacomo; Richeldi, Luca
Reliability of crackles in fibrotic interstitial lung disease: a prospective, longitudinal study
2024 Sgalla, Giacomo; Simonetti, Jacopo; Di Bartolomeo, Arianna; Magrì, Tonia; Iovene, Bruno; Pasciuto, Giuliana; Dell'Ariccia, Ruben; Varone, Francesco; Comes, Alessia; Leone, Paolo Maria; Piluso, Venere; Perrotta, Alessandro; Cicchetti, Giuseppe; Verdirosi, Diana; Richeldi, Luca
The management of Familial Pulmonary Fibrosis in different medical settings: Where does that leave us? An Italian nationwide survey
2024 Monteleone, Giorgio; ILDs Study Group Sip/Irs, Null; Bergantini, Laura; D'Alessandro, Miriana; Pianigiani, Tommaso; Simonetti, Jacopo; Iovene, Bruno; Varone, Francesco; Sgalla, Giacomo; Richeldi, Luca; Bargagli, Elena; Cameli, Paolo
A randomized trial of pamrevlumab in patients with COVID-19 pneumonia
2023 Sgalla, Giacomo; Leone, Paolo Maria; Gualano, Gina; Simonetti, Jacopo; Comes, Alessia; Verdirosi, Diana; Di Gennaro, Francesco; Larici, Anna Rita; Ianniello, Stefania; Cicchetti, Giuseppe; Fusco, Nicoletta; Pani, Marcello; Palmieri, Fabrizio; Richeldi, Luca
An up-to-date review of approved and emerging antibody therapies for idiopathic pulmonary fibrosis
2023 Simonetti, Jacopo; Sgalla, Giacomo; Richeldi, Luca
An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis: a look towards 2023 and beyond
2023 Sofia, Carmelo; Comes, Alessia; Sgalla, Giacomo; Richeldi, Luca
BI 1015550: an investigational phosphodiesterase 4B (PDE4B) inhibitor for lung function decline in idiopathic pulmonary fibrosis (IPF)
2023 Sgalla, Giacomo; Simonetti, Jacopo; Cortese, Stefania; Richeldi, Luca
Challenges in the diagnosis of idiopathic pulmonary fibrosis: the importance of a multidisciplinary approach
2023 Comes, Alessia; Sgalla, Giacomo; Ielo, Simone; Magrì, Tonia; Richeldi, Luca
Monitoring small airway dysfunction in connective tissue disease-related interstitial lung disease: a retrospective and prospective study
2023 Xu, Linrui; Sgalla, Giacomo; Wang, Faping; Zhu, Min; Li, Liangyuan; Li, Ping; Xie, Qibing; Lv, Xiaoyan; Yu, Jianqun; Wang, Gang; Wan, Huajing; Richeldi, Luca; Luo, Fengming
Acute Respiratory Distress Syndrome and Lung Fibrosis Complicating Surgery in a Patient with Crohn's Disease
2022 Sofia, Carmelo; Adiletta, Veronica; Iovene, Bruno; Sgalla, Giacomo; Richeldi, Luca
Advances with pharmacotherapy for the treatment of interstitial lung disease
2022 Comes, Alessia; Sgalla, Giacomo; Perrotta, Alessandro; Richeldi, Luca
Better be an Agnostic than a Believer (at Least in Pulmonary Fibrosis)
2022 Sgalla, Giacomo; Richeldi, Luca
COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis
2022 Sgalla, Giacomo; Magri', Tonia; Lerede, Marialessia; Comes, Alessia; Richeldi, Luca
Reply to: Huang and Wei, Kang et al., and Ehteshami-Afshar and Raj
2022 Sgalla, Giacomo; Richeldi, Luca
The Shorter, the Better: Can We Improve Efficiency of Idiopathic Pulmonary Fibrosis Trials?
2022 Sgalla, Giacomo; Wijsenbeek, M. S.; Richeldi, Luca
An updated safety review of the drug treatments for idiopathic pulmonary fibrosis
2021 Sgalla, Giacomo; Comes, Alessia; Richeldi, Luca
Emerging drugs for the treatment of idiopathic pulmonary fibrosis: 2020 phase II clinical trials
2021 Sgalla, Giacomo; Lerede, Marialessia; Richeldi, Luca
Phase three clinical trials in idiopathic pulmonary fibrosis
2021 Sgalla, Giacomo; Lerede, Marialessia; Richeldi, Luca
Data di pubblicazione | Titolo | Autore(i) | File |
---|---|---|---|
1-gen-2024 | Case of a 33-Year-Old Woman With Hemoptysis and Migrant Nodular Cavitary Lesions | Varone, Francesco; Martini, Alessia; Cicchetti, Giuseppe; Iovene, Bruno; Sgalla, Giacomo; Richeldi, Luca; Cancellieri, Alessandra | |
1-gen-2024 | Experimental autotaxin inhibitors for the treatment of idiopathic pulmonary fibrosis | Simonetti, Jacopo; Ficili, Marco; Sgalla, Giacomo; Richeldi, Luca | |
1-gen-2024 | Promising advances in treatments for the management of idiopathic pulmonary fibrosis | Sofia, Carmelo; Comes, Alessia; Sgalla, Giacomo; Richeldi, Luca | |
1-gen-2024 | Reliability of crackles in fibrotic interstitial lung disease: a prospective, longitudinal study | Sgalla, Giacomo; Simonetti, Jacopo; Di Bartolomeo, Arianna; Magrì, Tonia; Iovene, Bruno; Pasciuto, Giuliana; Dell'Ariccia, Ruben; Varone, Francesco; Comes, Alessia; Leone, Paolo Maria; Piluso, Venere; Perrotta, Alessandro; Cicchetti, Giuseppe; Verdirosi, Diana; Richeldi, Luca | |
1-gen-2024 | The management of Familial Pulmonary Fibrosis in different medical settings: Where does that leave us? An Italian nationwide survey | Monteleone, Giorgio; ILDs Study Group Sip/Irs, Null; Bergantini, Laura; D'Alessandro, Miriana; Pianigiani, Tommaso; Simonetti, Jacopo; Iovene, Bruno; Varone, Francesco; Sgalla, Giacomo; Richeldi, Luca; Bargagli, Elena; Cameli, Paolo | |
1-gen-2023 | A randomized trial of pamrevlumab in patients with COVID-19 pneumonia | Sgalla, Giacomo; Leone, Paolo Maria; Gualano, Gina; Simonetti, Jacopo; Comes, Alessia; Verdirosi, Diana; Di Gennaro, Francesco; Larici, Anna Rita; Ianniello, Stefania; Cicchetti, Giuseppe; Fusco, Nicoletta; Pani, Marcello; Palmieri, Fabrizio; Richeldi, Luca | |
1-gen-2023 | An up-to-date review of approved and emerging antibody therapies for idiopathic pulmonary fibrosis | Simonetti, Jacopo; Sgalla, Giacomo; Richeldi, Luca | |
1-gen-2023 | An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis: a look towards 2023 and beyond | Sofia, Carmelo; Comes, Alessia; Sgalla, Giacomo; Richeldi, Luca | |
1-gen-2023 | BI 1015550: an investigational phosphodiesterase 4B (PDE4B) inhibitor for lung function decline in idiopathic pulmonary fibrosis (IPF) | Sgalla, Giacomo; Simonetti, Jacopo; Cortese, Stefania; Richeldi, Luca | |
1-gen-2023 | Challenges in the diagnosis of idiopathic pulmonary fibrosis: the importance of a multidisciplinary approach | Comes, Alessia; Sgalla, Giacomo; Ielo, Simone; Magrì, Tonia; Richeldi, Luca | |
1-gen-2023 | Monitoring small airway dysfunction in connective tissue disease-related interstitial lung disease: a retrospective and prospective study | Xu, Linrui; Sgalla, Giacomo; Wang, Faping; Zhu, Min; Li, Liangyuan; Li, Ping; Xie, Qibing; Lv, Xiaoyan; Yu, Jianqun; Wang, Gang; Wan, Huajing; Richeldi, Luca; Luo, Fengming | |
1-gen-2022 | Acute Respiratory Distress Syndrome and Lung Fibrosis Complicating Surgery in a Patient with Crohn's Disease | Sofia, Carmelo; Adiletta, Veronica; Iovene, Bruno; Sgalla, Giacomo; Richeldi, Luca | |
1-gen-2022 | Advances with pharmacotherapy for the treatment of interstitial lung disease | Comes, Alessia; Sgalla, Giacomo; Perrotta, Alessandro; Richeldi, Luca | |
1-gen-2022 | Better be an Agnostic than a Believer (at Least in Pulmonary Fibrosis) | Sgalla, Giacomo; Richeldi, Luca | |
1-gen-2022 | COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis | Sgalla, Giacomo; Magri', Tonia; Lerede, Marialessia; Comes, Alessia; Richeldi, Luca | |
1-gen-2022 | Reply to: Huang and Wei, Kang et al., and Ehteshami-Afshar and Raj | Sgalla, Giacomo; Richeldi, Luca | |
1-gen-2022 | The Shorter, the Better: Can We Improve Efficiency of Idiopathic Pulmonary Fibrosis Trials? | Sgalla, Giacomo; Wijsenbeek, M. S.; Richeldi, Luca | |
1-gen-2021 | An updated safety review of the drug treatments for idiopathic pulmonary fibrosis | Sgalla, Giacomo; Comes, Alessia; Richeldi, Luca | |
1-gen-2021 | Emerging drugs for the treatment of idiopathic pulmonary fibrosis: 2020 phase II clinical trials | Sgalla, Giacomo; Lerede, Marialessia; Richeldi, Luca | |
1-gen-2021 | Phase three clinical trials in idiopathic pulmonary fibrosis | Sgalla, Giacomo; Lerede, Marialessia; Richeldi, Luca |